APOE and Alzheimer disease: Having confirmed that the extracted protein is of appropriate quality, we then applied a comprehensive workflow to enable us to assess (at the protein level) the relative contribution of both regional vulnerability and APOE variants as a risk factors to AD pathogenesis (Fig. 1c, Additional file 7: Figure S1) [15, 32].